Treatment Adherence of Home Parenteral Nutrition in Patients With Chronic Intestinal Failure. (QANPIC)
What Treatment Adherence for Home Parenteral Nutrition in Patients With Chronic Intestinal Failure ?
1 other identifier
observational
126
1 country
6
Brief Summary
This observational, cross-sectionnal, multicentric study evaluates treatment adherence of home parenteral nutrition in patients with chronic intestinal failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2023
Shorter than P25 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2023
CompletedFirst Posted
Study publicly available on registry
May 12, 2023
CompletedStudy Start
First participant enrolled
June 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2024
CompletedApril 29, 2024
April 1, 2024
7 months
April 20, 2023
April 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in the volume of parenteral nutrition
A 10% (or more) difference between " ideal " and " final " prescriptions (one week's assessment of volume difference in mL) And/or During telephone survey, highlighting a 10% (or more) difference in nutrition received, compared to what is indicated on the prescription (assessment done on the difference in volume in mL over a week).
Inclusion visit, 8 weeks
Secondary Outcomes (3)
Patient's compliance
Inclusion visit
Anxiety and depression symptom
Inclusion visit
Patient's trust
Inclusion visit
Study Arms (1)
Chronic intestinal failure patient
Patient with chronic intestinal failure and with home parenteral nutrition treatment stable for at least 3 months and with home parenteral nutrition treatment for at least 6 months.
Interventions
The negociation component will be assessed during an office visit with the help of forms, by the difference between " ideal " parenteral nutrition prescription proposed by prescriber and the " final " prescription, that the patient ultimately receives at the end of the office visit. The compliance component will be assessed by a telephone interview, 8 weeks after the office visit.
Eligibility Criteria
Patient with chronic intestinal failure
You may qualify if:
- Age 18 or older.
- Diagnosis of CIF (insufficiency of intestinal absorptive, motor or vascular functions that require parenteral nutrition).
- Home parenteral nutrition treatment for at least 6 months.
- With home parenteral nutrition treatment stable for at least 3 months.
- Agreeing to participate in research protocol.
You may not qualify if:
- Any condition that does not let a telephone interview (example : deafness, severe neurocognitive impairment).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
CHU de Grenoble
Grenoble, 38043, France
CHU Limoges
Limoges, France
Institut régional du cancer Montpellier
Montpellier, France
CHU de Nantes
Nantes, France
Hôpital de l'Archet
Nice, 06202, France
CHU Bordeaux
Pessac, 33600, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Florian POULLENOT, MD
University Hospital, Bordeaux
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2023
First Posted
May 12, 2023
Study Start
June 29, 2023
Primary Completion
January 25, 2024
Study Completion
January 25, 2024
Last Updated
April 29, 2024
Record last verified: 2024-04